Europe Intravenous (IV) Equipment Market Outlook, 2028

The European healthcare business has seen a spike in demand and innovation in the field of intravenous (IV) equipment. The IV equipment market is an essential component of modern healthcare, assisting in the delivery of fluids, medicines, and nutrients straight into a patient's bloodstream. Europe, which is known for its strong healthcare infrastructure and emphasis on technical breakthroughs, has seen substantial expansion in this industry. Several reasons contribute to Europe's high growth in the IV equipment market. The increased frequency of chronic diseases and the increasing number of patients requiring long-term care are two major drivers.

As a result, there is a greater need for efficient and dependable IV equipment to properly administer treatments and medications. Furthermore, technological improvements led to the creation of sophisticated IV equipment that enables precise dosage delivery, lowering the risk of errors and improving patient safety.

The integration of electronic medical records (EMRs) with IV equipment has sped up the administration process, allowing for better patient monitoring and management. In recent years, there have been amazing advancements in IV equipment technology. In the European market, smart pumps and infusion systems with expanded connection features have gained appeal. Wireless connectivity, dose error reduction systems, and interfaces with hospital information systems are just a few of the features available on these devices, all of which contribute to more efficient and accurate treatment delivery. Furthermore, wearable and portable IV devices have emerged in the market. These advancements give patients more mobility during treatments, allowing them to go about their regular lives while receiving vital therapies. These developments not only increase patient comfort but also contribute to shorter hospital stays, lowering healthcare expenses.

Furthermore, the growing emphasis on home healthcare and the transition to ambulatory care settings are expected to fuel demand for portable and simple-to-use IV equipment. This tendency is consistent with the larger goal of increasing patient outcomes while decreasing the burden on traditional healthcare facilities.

According to the research report,"Europe Intravenous (IV) Equipments Market Outlook, 2028,", the Europe Intravenous (IV) Equipments market is anticipated to grow at a 5% CAGR by 2023-28. Europe is well-known for its well-established healthcare systems and infrastructure. The region is home to a network of cutting-edge hospitals, research institutes, and healthcare facilities that prioritise patient care. This solid infrastructure generates a favourable environment for the adoption and use of modern IV equipment. Europe has always been at the forefront of technological advancements in healthcare. The region continually invests in R&D, resulting in the production of cutting-edge IV equipment with innovative characteristics. European firms frequently pioneer advances that set worldwide norms in IV therapy, from smart pumps to integrated systems.

European countries frequently devote a significant portion of their GDP to healthcare, allowing for significant investment in medical technologies. This commitment to healthcare investment makes it easier to implement novel IV equipment and technologies in a variety of healthcare settings. Medical tourists seeking specialised treatments go to several European countries noted for their superior healthcare facilities and expertise. The availability of cutting-edge IV equipment adds to the allure of these places, fueling industry expansion and technological breakthroughs. The IV equipment industry benefits from Europe's strong presence in regenerative medicine and biotechnology. Advanced therapies, such as cell-based treatments, frequently necessitate specialised IV delivery systems, encouraging the development of customised equipment to support these cutting-edge therapies.

Based on report market is divided into six major countries, Germany, United Kingdom, France, Italy, Spain and Russia. Germany is expected to lead the Europe Intravenous (IV) Equipments market with significant market share.

The intravenous (IV) equipment market in Germany has witnessed a significant boom over the last few decades, driven by a number of major factors. This vital industry encompasses a wide range of devices and consumables used to deliver fluids, medicines, and nutrients directly into a patient's circulation. The landscape of this market in Germany is defined by a number of aspects that contribute to its expansion and innovation. The good healthcare infrastructure in Germany is the basis of the booming IV equipment market. The country's commitment to providing high-quality healthcare is reflected in its cutting-edge hospitals and clinics.

The persistent pursuit of innovation has resulted in the development of cutting-edge IV equipment, hence establishing a favourable climate for market growth. Germany has a powerful and well-established healthcare system that includes cutting-edge hospitals, research facilities, and a large network of healthcare specialists.

This infrastructure facilitates the adoption and use of new medical technologies, such as IV equipment. The country has a strong medical equipment manufacturing base. German businesses are known for providing high-quality medical equipment, and their skill in precision engineering and manufacturing aids in the development of reliable and effective IV equipment.

Based on product European market is bifurcated into IV catheters, infusion pumps, administration sets, securement devices, needless connectors, stopcocks and check valves, drip chambers and others. Among them IV catheters product is expected to lead the Europe Intravenous Equipments market.

IV catheters are essential components of IV therapy since they are the primary means of gaining access to a patient's bloodstream for the administration of fluids, drugs, and therapies. As a result of their critical function in delivering healthcare interventions, they are an important and in-demand product in the IV equipment industry. Continuous improvements in IV catheter technology have led to the creation of new and improved catheter designs. These advancements aim to increase patient comfort, decrease insertion-related problems such as infections and phlebitis, and improve the overall safety and efficiency of IV therapy. The prevalence of chronic diseases in Europe is increasing, necessitating long-term or repeated IV treatments. The need for IV catheters remains high in order to enable the delivery of medications and therapies for disorders such as diabetes, cardiovascular disease, and cancer.

The European healthcare system places a premium on adhering to strict quality standards and regulations. IV catheters, as vital medical equipment, are subject to stringent quality control measures to ensure their safety, efficacy, and compliance with regulatory standards, instilling confidence in healthcare providers and patients. IV catheters are relatively inexpensive when compared to other IV equipment, making them widely available in a variety of healthcare settings. Their price and versatility lead to their supremacy in the European IV equipment industry.

In terms of end user segment market is bifurcated into hospitals, clinics, home care settings and others. Among them hospitals is major end user of Intravenous (IV) equipments in Europe. Furthermore based on indication market is bifurcated into cardiovascular disorders & hypertension, pregnancy, diabetes, respiratory diseases, cancer, movement disorders, wound care and other indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV).

Hospitals serve a wide spectrum of patients with varied medical conditions, many of which require immediate and intensive treatment. IV therapy is crucial in hospitals for providing drugs, fluids, and treatments quickly and effectively, making IV equipment essential instruments in treating acute and critical healthcare demands. Hospitals are essentially inpatient treatment facilities where patients can stay for short or long periods of time. IV equipment, such as infusion pumps, IV catheters, and sets, is critical for providing continuous treatments, drugs, and sustenance to patients during their hospital stays.

Hospitals often handle a significant volume of patients on a daily basis, demanding a consistent and substantial supply of IV equipment. The demand for IV therapy devices is constantly strong in these settings, impacting the market's reliance on hospitals as important purchasers of IV therapy devices.

Cardiovascular problems, such as heart attacks, arrhythmias, and heart failure, frequently require prompt and intense treatment. IV therapy becomes vital in urgent situations for swiftly giving medications such as antiplatelet agents, anticoagulants, and vasodilators to stabilise patients or manage acute symptoms in patients with cardiovascular problems. IV treatment is critical for maintaining fluid balance and providing hemodynamic support. Fluids, electrolytes, and vasoactive medications delivered intravenously aid in the regulation of blood pressure, cardiac output, and organ perfusion, especially in critical situations. During invasive operations such as cardiac catheterization, angioplasty, or interventions such as delivering thrombolytic therapy for acute coronary syndromes, IV equipment is frequently used to deliver drugs or contrast agents directly into the bloodstream.

Companies Covered in this report:

Becton, Dickinson and Company, B. Braun Melsungen AG, Baxter International Inc., ICU Medical, Inc., Medtronic PLC, Moog Inc., Terumo Corporation, Teleflex Incorporated, Cardinal Health, Inc., Elcam Medical Inc.

Considered in this report:

• Geography: Europe
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Europe Intravenous (IV) Equipments market Outlook with its value and forecast along with its segments
• Country-wise Intravenous (IV) Equipments market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia

By Product:

• IV Catheters
• Infusion Pumps
• Administration Sets
• Securement Devices
• Needless Connectors
• Stopcocks and Check Valves
• Drip Chambers
• Others

By End User:

• Hospital
• Clinics
• Home Care Settings
• Others

By Indication:

• Cardiovascular Disorders & Hypertension
• Pregnancy
• Diabetes
• Respiratory Diseases
• Cancer
• Movement Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Intravenous (IV) Equipments industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.


This product will be delivered within 2 business days.